Early ribavirin treatment and avoidance of corticosteroids in hepatitis C virus (HCV)-positive liver transplant recipients: Interim report of a prospective randomized trial

被引：19
作者：
Belli, LS
Alberti, AB
Rondinara, GF
de Carlis, L
Corti, A
Mazza, E
Airoldi, A
Cernuschi, A
de Gasperi, A
Forti, D
Pinzello, GB
机构：
[1] Osped Niguarda Ca Granda, Div Med Crespi, I-20162 Milan, Italy
[2] Osped Niguarda Ca Granda, Div Chirurg Pizzamiglio 2, Ctr Trapianti Organi Addominali, I-20162 Milan, Italy
[3] Osped Niguarda Ca Granda, Serv Anestes, I-20162 Milan, Italy
来源：
TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 1-2期
关键词：
D O I：
10.1016/S0041-1345(00)02507-0
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1353 / 1354
页数：2
相关论文
共 5 条
[1]  
Demetris AJ, 1997, HEPATOLOGY, V25, P658
[2]  
ISHOCK K, 1995, J HEPATOL, V22, P696
[3]  
MAGRIN S, 1994, HEPATOLOGY, V19, P273
[4]  
SHEINER PA, 1995, HEPATOLOGY, V21, P30, DOI 10.1016/0270-9139(95)90404-2
[5]   Recurrent hepatitis C virus hepatitis in liver transplant recipients receiving tacrolimus: Association with rejection and increased immunosuppression after transplantation [J].
Singh, N ;
Gayowski, T ;
Ndimbie, OK ;
Nedjar, S ;
Wagener, MM ;
Yu, VL .
SURGERY, 1996, 119 (04) :452-456
1